Sosei Group
Japanese biopharmaceutical company that develops and commercializes innovative drugs..
Enterprise value
$870m
Share price
$16.55 4565.T
Recent deals
Corporate Venture Fund
loading funding rounds…
Resona Capital(exited)
Yasuda Enterprise Development(exited)
Mitsui Global Investment(exited)
JAFCO(exited)
Japan Asia Investment(exited)
Nomura(exited)
Scottish Equity Partners(exited)
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (9 %) | 100 % | (12 %) | (18 %) | 126 % | 23 % | 12 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 40 % | 30 % | 32 % | (45 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 17 % | 6 % | 2 % | (56 %) | (17 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 43 % | 33 % | 48 % | 79 % | 41 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Sosei Group
Edit
ACQUISITION by Sosei Group Feb 2015
ACQUISITION by Sosei Group Jul 2005
ACQUISITION Apr 2021